Lonza unrolls Bioscience strategy

Article Abstract:

Lonza unveiled its business strategy for its new Bioscience division. The company projected making several investments for the said division which will be comprised of four business units: Rapid Testing Systems, Cell Therapy, Media and Cell Discovery, and Molecular Biology. Company forecasts and sales are also discussed.

Forecasts, trends, outlooks, CHEMICALS AND ALLIED PRODUCTS, Switzerland, Chemical industry, Strategic planning (Business), Pesticides industry, Herbicides, Company business forecast/projection, Company forecasts, Sulphur industry, Lonza Group Ltd.

---

Aptuit adds on Evotec CPD

Article Abstract:

Aptuit is acquiring Germany-based Evotec's UK-based Chemical & Pharmaceutical Development (CPD) business . The deal, which is worth around 46.4 mil lion euros, will close by the end of November 2008 and it involves the transfer of e mployees and facilities worldwide. The scope of the deal is discussed.

United Kingdom, Acquisitions & mergers, Pharmaceutical preparations, Drugs, Biotechnology industry, Pharmaceutical industry, Mergers, acquisitions and divestments, Biotechnology industries, Company acquisition/merger, Evotec Technologies GmbH

---

Similar abstracts:

• Abstracts: ICI: a chemicals icon exits the stage. DSM buys Pentapharm
• Abstracts: EFCG demands excipient standards. When is an off-patent product not a generic?
• Abstracts: Infrared study of the effect of hydration on the amide I band and aggregation properties of helical peptides. On the temperature dependence of amide I frequencies of peptides in solution

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.